Cases

Due diligence evaluation for a series of small molecules

The client, a small investment company, requested a significant evaluation of all CMC and non-clinical data available on a series of compounds of a specific company, before deciding on in-licensing these compounds..... Read more >




Evaluation of non-clinical study results

A small biotechnology company needed to critically evaluate the results of several non-clinical toxicology studies it outsourced at a third party CRO..... Read more >




Multidisciplinary development of a fixed dose combination product

A start-up pharmaceutical company had successfully conducted a proof-of-concept (POC) study in patients with a CNS disease. .... Read more >




Multidisciplinary development of a small molecule

A small pharmaceutical company with a pipeline composed of several compounds in different phases of development gradually reached the maximum capacity of its internal staff. .... Read more >




Non-clinical development of a small molecule, incl. training and a due diligence

A spin-off company from a university intended to develop a small molecule via non-clinical studies into phase I clinical trials with the aim to license it to a partner..... Read more >




Scientific due diligence evaluation for a series of dietary supplements

The client, a venture capitalist (VC), was looking to in-licensing a series of dietary supplements of a certain food company, which had a limited portfolio of non-clinical and clinical data. .... Read more >




Writing of Modules for generic drug applications

A pharmaceutical company specialized in producing and marketing of generic drug products wanted to file an application for a new generic drug. .... Read more >